联环药业：公司他达拉非片(20mg)可在加纳合法销售

Core Viewpoint - The company has received regulatory approval for the sale of Tadalafil tablets (20mg) in Ghana, marking a significant step in its international expansion efforts [2] Group 1: Regulatory Approval - The company announced that it has obtained a Drug Registration Certificate from the Food and Drug Authority of the Republic of Ghana for Tadalafil tablets (20mg) [2] - This approval allows the company to legally sell Tadalafil tablets in Ghana, which is a PDE5 inhibitor used for treating erectile dysfunction and benign prostatic hyperplasia symptoms [2] Group 2: Financial Impact - The projected sales revenue for Tadalafil tablets in the fiscal year 2024 is approximately 23.08 million RMB [2] - The company anticipates that the acquisition of the Drug Registration Certificate will not have a significant impact on its recent operating performance [2]